Search results
Showing 3001 to 3015 of 7690 results
Find out more about the committee members by reading their biographies. Prof Stephen G O'Brien BSc (Hons) PhD MBChB FRCP MRCPath (chair) Biography
Find out more about NICE technology appraisals advisory committee D members
This indicator covers the proportion of eligible people with diabetes who are suspended from diabetic eye screening due to previous screening results. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG89
Agenda and papers of the NICE public board meeting on 15 May 2024
Agenda and papers of the NICE public board meeting on 13 December 2023
Links to our annual reports and business plan
Data on the recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.
Data on the cancer recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.
We are evolving to make sure we’re meeting the changing needs of the health and care system
Information about providers of medical and healthcare related content under the NICE Electronic and Print Content Framework Agreement
Where you can find more information about how we operate
This indicator covers the percentage of patients with non-diabetic hyperglycaemia who have had an HbA1c test or FPG test in the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM150
Our board has 2 sub-committees: the audit and risk assurance committee and the remuneration committee . Audit and risk assurance committee The audit
Working examples of quality improvement in health and social care services. Quality improvement, efficiency changes, cost savings, good practice, shared learning.
This indicator covers establishing and maintaining a register of all patients on the autistic spectrum. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM153